Blocking swelling‐activated chloride current inhibits mouse liver cell proliferation
Open Access
- 1 May 2001
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 532 (3) , 661-672
- https://doi.org/10.1111/j.1469-7793.2001.0661e.x
Abstract
1 A non‐transformed mouse liver cell line (AML12) was used to show that blocking swelling‐activated membrane Cl− current inhibits hepatocyte proliferation. 2 Two morphologically distinguishable cell populations exhibited distinctly different responses to hypotonic stress. Hypotonic stress (from 280 to 221 mosmol kg−1) to rounded, dividing cells activated an ATP‐dependent, outwardly rectifying, whole‐cell Cl− current, which took 10 min to reach maximum conductance. A similar anionic current was present spontaneously in 20 % of the dividing cells. Hypotonic stress to flattened, non‐dividing cells activated no additional current. 3 The Eisenman halide permeability sequence of swelling‐activated anionic current in the dividing cells was SCN− > I− > Br− > Cl− > gluconate. 4 Addition of either 4,4′‐diisothiocyanatostilbene‐2,2′‐disulfonate (DIDS), 5‐nitro‐2‐(3‐phenylpropylamino) benzoic acid (NPPB), tamoxifen or mibefradil inhibited swelling‐activated anionic current. Hyperosmolarity by added sucrose inhibited the spontaneous anionic current in dividing cells. 5 Added Cl− channel blockers NPPB (IC50= 40 μm), DIDS (IC50= 31 μm), tamoxifen (IC50= 1.3 μm) and mibefradil (IC50= 7 μm) inhibited proliferative growth of AML12 as determined by cell counts over 4 days or by protein accumulation over 2 days. Only the inhibitory effects of NPPB and mibefradil reversed with the drug washout. Hyperosmolarity by added sucrose (50 and 100 mm) also inhibited cell proliferation. 6 Of the hydrophobic inhibitors neither NPPB at 40 μm nor tamoxifen at 1.3 μm, added for 48 h, reduced cellular ATP; however, DIDS at 31 μm significantly reduced cellular ATP with an equivalent increase in cellular ADP. 7 We conclude that those membrane Cl− currents that can be activated by hypotonic stress are involved in mechanisms controlling liver cell growth, and that NPPB, tamoxifen and mibefradil at their IC50 for growth do not suppress the metabolism of mouse hepatocytes.Keywords
This publication has 57 references indexed in Scilit:
- K+ channel block‐induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferationThe Journal of Physiology, 1998
- Volume-activated Cl− channelsGeneral Pharmacology: The Vascular System, 1996
- Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformation*1Hepatology, 1995
- Introduction of a murine p53 mutation corresponding to human codon 249 into a murine hepatocyte cell line results in growth advantage, but not in transformationHepatology, 1995
- Effects of chloride transport inhibitors on intestinal fluid and ion transport in vivo and in vitroActa Physiologica Scandinavica, 1993
- Regions involved in the opening of CIC-2 chloride channel by voltage and cell volumeNature, 1992
- Effects of hyperosmotic medium on hepatocyte volume, transmembrane potential and intracellular K+ activityBiochimica et Biophysica Acta (BBA) - Biomembranes, 1991
- Cell Cycle Dependence of Chloride Permeability in Normal and Cystic Fibrosis LymphocytesScience, 1990
- Tamoxifen blocks both proliferation and voltage-dependent K+ channels of neuroblastoma cellsCellular Signalling, 1990
- A new protocol for studying the early events during liver regenerationLife Sciences, 1978